Abstract
Tumor-associated macrophages play a central role in tumor progression and metastasis. Macrophages can also promote the resistance of malignant cells to chemotherapy by stimulating the upregulation of cytidine deaminase, an intracellular enzyme that catabolizes the active form of gemcitabine. Targeting macrophage-dependent chemoresistance may reduce tumor-associated morbidity and mortality.
| Original language | English |
|---|---|
| Article number | e27231 |
| Journal | OncoImmunology |
| Volume | 2 |
| Issue number | 12 |
| DOIs | |
| State | Published - 1 Jan 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chemotherapy
- Cytidine deaminase
- Gemcitabine
- Macrophages
- Pancreatic ductal adenocarcinoma
- Resistance
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology
Fingerprint
Dive into the research topics of 'Macrophages increase the resistance of pancreatic adenocarcinoma cells to gemcitabine by upregulating cytidine deaminase'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver